lilly's glp 1 Administration Anounces Landmark GLP-1 Pricing Agreement with Eli Lilly and Novo Nordisk Eli Lilly's Orforglipron Beats Novo

Research shows that the mean amount of body weight loss for obese and overweight women with weight-related medical conditions was 15% after 68 weeks (nearly 16 months)

Miki K, Murakami M, Oka H, Onozawa K, Yoshida S, Osada K (2016) Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Theres no strong evidence that GLP-1 drugs interfere with HS medications, but you should always be cautious when adding new drugs to your regimen